Bionic Sight Llc

This early-stage study is testing a one-time gene therapy injection (called BS01) for people with a severe form of dry age-related macular degeneration (AMD) that causes blind spots. The goal is to see if the treatment is safe and if it can help slow down or stop the progression …

This trial is testing a new gene therapy called BS01 for people with retinitis pigmentosa, a genetic eye disease that causes vision loss. The therapy uses a harmless virus to deliver a special light-sensitive protein directly into the eye, aiming to help remaining cells detect li…